1.Evidence-based evaluation on safety of Tripterygium wilfordii preparations.
Xue FENG ; Sai-Nan FANG ; Yu-Xin GAO ; Jian-Ping LIU ; Wei CHEN
China Journal of Chinese Materia Medica 2018;43(3):425-439
The study was aimed to conduct an evidence-based evaluation on the safety of Tripterygium wilfordii(TW) preparations through a method combined bibliometrics research with evidence-based evaluation research, to provide evidence-based safety information of the TW preparations(nephrotoxicity) for the government decision-making and clinical application, and to provides methods and suggestions for evaluating nephrotoxicity of Chinese herbal medicine(CHM) in the future. We searched relevant databases at home and abroad systematically, and six Chinese and English databases including CNKI, SinoMed, VIP, WanFang, PubMed, and Cochrane library were comprehensively searched. All types of research documents about the safety of TW preparations. Literature were screened and extracted based on inclusion and exclusion criteria. The methodology quality of all included studies were assessed by internationally recognized evaluation tools or standards. The incidence rate was analyzed by using R software. Subgroup analysis were conducted according to the type of disease treated, drug delivery way, medication time, and study types.
Bibliometrics
;
Drugs, Chinese Herbal
;
standards
;
Tripterygium
2.Processing technology for reducing toxicity of fried Tripterygium wilfordii in Lysimachia christinae decoction.
Yue-Chen GUAN ; Jun-Ming WANG ; Ling-Ling SONG ; Xiao-Hui WU ; Chen LIU ; Jie XUE
China Journal of Chinese Materia Medica 2021;46(5):1128-1133
On the basis of the previous work of the research group, the orthogonal design method was further used to optimize the processing technology for reducing toxicity of fried Tripterygium wilfordii in Lysimachia christinae Decoction. A total of 9 processed products of T.wilfordii in L.christinae decoction were prepared by four factors and three levels orthogonal design table. The contents of triptolide in T.wilfordii were determined by high performance liquid chromatography(HPLC) before and after processing: 4.27, 3.92, 3.57, 2.75, 2.42, 2.66, 3.51, 1.87, 1.75, 2.03 μg·g~(-1). On this basis, the above processed products were orally given to mice for 28 days. 12 hours after the last administration, food fasting except water was provided, and 24 hours later, the eyeballs were taken for blood and liver tissue. Serum biochemical indexes, liver lipid peroxidation and antioxidant related indexes were detected by kit method. Twenty-eight days after oral administration of raw T.wilfordii, the levels of serum alanine aminotransferase(AST), alanine aminotransferase(ALT), alkaline phosphatase(ALP) and liver malondialdehyde(MDA) in mice increased by 91%(P<0.01), 46%(P<0.05), 73%(P<0.01) and 99%(P<0.01), while the liver antioxidant indexes such as superoxide dismutase(SOD), glutathione(GSH), glutathione peroxidase(GPX) and glutathione-S transferase(GST) significantly decreased(P<0.01). After administration of the processed products, the above indexes were significantly reversed(P<0.01 or P<0.05). Especially, the processing conditions of A_3B_2C_1D_3 had the best detoxification effect on T.wilfordii, which decreased the high levels of AST, ALT, ALP and MDA by 49%(P<0.01), 32%(P<0.01), 42%(P<0.01), and 17%(P<0.05). Therefore, the best processing conditions for T.wilfordii in L.christinae decoction were A_3B_2C_1D_3, namely "15% mass fraction of L.christinae, 1 h moistening time, 160 ℃ frying temperature, and 9 min frying time".
Animals
;
Antioxidants
;
Liver
;
Mice
;
Primulaceae
;
Technology
;
Tripterygium
3.Research progress on chemical constituents and quality control of Tripterygium wilfordii preparations.
Ya-Dan WANG ; Qi WANG ; Jian-Bao ZHANG ; Zhong DAI ; Na LIN ; Xian-Fu WU ; Shuang-Cheng MA
China Journal of Chinese Materia Medica 2019;44(16):3368-3373
Tripterygium wilfordii preparations,with various biological activities such as immunosuppressive,anti-inflammatory and anti-cancer effects,are widely used in the treatment of autoimmune diseases such as rheumatoid arthritis,lupus erythematosus,and nephrotic syndrome. They have definite therapeutic effect,but often cause serious adverse reactions and result in damages to liver,kidney,blood,reproduction,and other systems due to their complex compositions,great toxicity,and narrow margin between the toxic and therapeutic dosages. At present,T. wilfordii preparations produced by different manufacturers exhibit large variations in clinical efficacy and side effects in account of their different chemical compositions and quality fluctuation due to differences in raw materials and production process. However,the existing quality standards are controversial in terms of index components and content limit,which cannot be effectively used for the overall quality control of the preparations. In this paper,the research progress on chemical constituents,quality standard and quality control methods of four T. wilfordii preparations including Tripterygium Tablets,Tripterygium Zongtie Tablets,Tripterygium Shuangceng Tablets and Tripterygium Glycosides Tablets was reviewed,in order to provide ideas and reference for the quality improvement of this type of preparations.
Drugs, Chinese Herbal
;
standards
;
Quality Control
;
Tablets
;
Tripterygium
;
chemistry
4.Collaborative innovation boosting the safe and rational use of traditional Chinese medicines.
China Journal of Chinese Materia Medica 2019;44(16):3365-3367
As entering a new era,our country has introduced a series of favorable policies,which may provide the powerful and new momentum for the development of traditional Chinese medicine( TCM). However,more and more attentions have been paid to the safety and effectiveness of TCM. Tripterygium wilfordii Hook.f. is one of Chinese herbs with clinical efficacy and safety risk. In recent years,accumulating groups have carried out a series of exploratory studies on the clinical rational use of T. wilfordii-related preparations. Considering this situation,the goal of this special issue is to bring together a collection of original research and review articles addressing the expanding field of T. wilfordii. The special issue covers the clinical application,pharmacodynamics,toxicology,pharmacodynamics,resource identification and molecular pharmacognosy of T. wilfordii-related preparations. It focuses on the multi-disciplinary collaborative innovation,and may provide a stimulating resource for the fascinating subject of the safe and rational use of TCM,as well as have important practical significance and promotion value for the healthy development of TCM industry.
Drugs, Chinese Herbal
;
standards
;
Medicine, Chinese Traditional
;
Tripterygium
5.Pressurized liquid extraction of Tripterygiumw wilfordii polyglycosides and optimization of extraction conditions.
Lei YANG ; Tong LI ; Yuangang ZU
China Journal of Chinese Materia Medica 2010;35(1):44-48
OBJECTIVETo investigate the extraction method of polyglycosides from Tripterygium wilfordii.
METHODThe extraction method of pressurized liquid extraction was employed and chromogenic colorimetric technique were used for quantitative analysis. Based on the single-factor experiment, according to the center combination design this paper used three factors and three levels of response surface methodology for process optimization.
RESULTThe optimized conditions were as follows: ratio of solid to liquid was 1:9.5, at the temperature of 115 degrees C for 80 minutes, the actual extract ratio and purity of polyglycosides obtained were 0.21% and 0.52%, respectively.
CONCLUSIONThe method of pressurized liquid extraction has obvious advantages over conventional reflux extracting.
Glycosides ; isolation & purification ; Plant Extracts ; chemistry ; Pressure ; Tripterygium ; chemistry
6.Meta-analysis of blood system adverse events of Tripterygium wilfordii.
Zhi-xia LI ; Dong-mei MA ; Xing-hua YANG ; Feng SUN ; Kai YU ; Si-yan ZHAN
China Journal of Chinese Materia Medica 2015;40(2):339-345
A systematic review was undertaken, including studies that evaluated the incidence of the blood system adverse events of Tripterygium wilfordii (TWP). Medline, Embase and the Cochrane library were searched for relevant studies, including RCT, cohort studies and case series, of patients treated with TWP published in English and Chinese from inception up until May 25th, 2013 with the keywords including "Tripterygium wilfordii", "toxicity", "reproductive", "side effect", "adverse", "safety" and "tolerability". Relevant information was extracted and the incidence of the blood system adverse events was pooled with MetaAnalyst software. Besides, subgroup and sensitivity analyses were performed based on age, mode of medicine, observation time and disease system. According to inclusion and exclusion criteria, a total of 49 articles were included in the meta-analysis, they were split into 54 researches incorporated in the analysis. There is a large degree of heterogeneity among the studies, so data was analyzed using random-effects model and the summary estimates of incidence of the blood system adverse events was 6.1%. The weighted combined incidence of three major blood system adverse events were white-blood cells decreasing 5.6% (95% CI, 4.3% - 7.3%), hemoglobin decreasing 1.7% (95% CI, 0.5% - 5.0%) and platelet decreasing 1.8% (95% CI, 1.0% - 3.1%), respectively . Sensitivity analyses based on 45 studies with high quality showed the combined value was close to the summary estimate of total 54 studies. The current evidence indicates that the incidence of the blood system adverse events induced by TWP was high; attentions should be paid on to the prevention and treatment of the blood system adverse events.
Blood Cells
;
drug effects
;
Hemoglobins
;
analysis
;
Humans
;
Tripterygium
;
adverse effects
7.CiteSpace knowledge map analysis of research progress on Tripterygium wilfordii toxicity.
Shan-Shan HAN ; Yan-Lin DAI ; Ying DING ; Xia ZHANG ; Li-Hui SUN ; Min GAO
China Journal of Chinese Materia Medica 2022;47(4):1085-1094
This study systematically searched CNKI and Web of Science(WoS) for the research papers on the toxicity of Tripterygium wilfordii included from database inception to August 31, 2021, and visually displayed the authors, research institutions, keywords, and other contents using bibliometrics and CiteSpace 5.8.3. Furthermore, the current situation and research progress on T. wilfordii safety were also analyzed based on information extraction to find the research hotspot, evolution path, and development trend, and to provide references for future research. A total of 1 876 Chinese papers and 243 English papers were included in the study. The analysis of authors showed that WANG Qi and ZHANG Luyong had the most publications in Chinese and English papers, respectively. According to the analysis of research institutions, National Institutes for Food and Drug Control and China Pharmaceutical University possessed the largest number of Chinese and English papers, respectively, but there was less cooperation between them. The analysis of keywords in Chinese and English papers showed that the research contents of the safety of T. wilfordii mainly focused on clinical monitoring, mechanism, dosage form improvement, quality standard, component analysis, monomer research, efficiency and toxicity reduction, etc. Metabonomics, tripterine, and the underlying mechanism of toxicity were the research hotspots in the future. At present, the research on the toxicity of T. wilfordii is still under development. It is necessary to highlight the in-depth research and strengthen the inter-group and inter-region cooperation of authors or institutions to provide references for the research on the toxicity of T. wilfordii.
Bibliometrics
;
China
;
Drugs, Chinese Herbal/toxicity*
;
Humans
;
Tripterygium
8.Application of evidence-based rapid review in studying nephrotoxicity of Tripterygium wilfordii preparation.
Xue FENG ; Sai-Nan FANG ; Yu-Xin GAO ; Jian-Ping LIU ; Wei CHEN
China Journal of Chinese Materia Medica 2018;43(3):446-451
To investigate the feasibility of applying the evidence-based rapid review in studying the nephrotoxicity of Tripterygium wilfordii preparation. We used four methods in relevant studies on the nephrotoxicity of T. wilfordii preparation. The first method had no limitation on any search terms, which was a traditional approach to retrieve systematic reviews. The second method limited the relevant search terms of T. wilfordii preparation to "all of CHMs containing T. wilfordii preparation approved by CFDA". The third method was to limit the relevant retrieval terms of nephrotoxicity as the "most frequently reported terms related to nephrotoxicity found in the study literature screening process in the early stage of systematic review". The fourth method was to limit the search terms relating to both T. wilfordii preparation and nephrotoxicity. Finally, the results of the last three search methods were compared with those of the first search method, and the feasibility of the rapid review method in the study for the nephrotoxicity of CHM was discussed. For the total number of literatures searched, the fourth method had the smallest number of literatures. For the number of articles in line with the inclusion criteria, the second method had the largest number of eligible literatures. For the type of literatures included, the forth method had a higher coincidence degree. The forth method was the best one, because it was not only consistent with the results, but also could minimize the workload. Rapid review is feasible in the study of nephrotoxicity of T. wilfordii.
Drugs, Chinese Herbal
;
toxicity
;
Humans
;
Kidney
;
drug effects
;
Research Design
;
Systematic Reviews as Topic
;
Tripterygium
;
toxicity
9.Evaluation of reporting quality of RCT on nephrotoxicity of Tripterygium wilfordii preparations according to CONSORT HARMs statement.
Xue FENG ; Sai-Nan FANG ; Yu-Xin GAO ; Jian-Ping LIU ; Wei CHEN
China Journal of Chinese Materia Medica 2018;43(3):440-445
To evaluate the quality of randomized controlled trials(RCT) on nephrotoxicity of Tripterygium wilfordii preparations according to the CONSORT HARMs statement. The report quality of each included study was evaluated according to the CONSORT HARMs statement, and the number of entries that comply with CONSORT HARMs statement was calculated in each study to evaluate the report quality on nephrotoxicity-related adverse reactions of T. wilfordii preparations and summarize the problems in domestic studies on nephrotoxicity-related adverse reactions. A total of 16 RCTs were included, with an average of 7 entries complying with CONSORT HARMs statement per study. The report of the nephrotoxic-associated RCT of T. wilfordii preparations was of poor quality and the most non-repeating entries included the following ones: using validated tools to report adverse effects, standards for coding of the adverse reactions, describing how and when to collect data on adverse reactions in Method, describing how adverse reactions are attributed to T. wilfordii, clearly stating who has reported the adverse reactions, describing the analysis method of adverse reactions, describing the method of collecting recurrent adverse reaction data, describing any subgroup analysis and exploratory analysis associated with the hazard. We suggest that the studies on adverse reactions of traditional Chinese medicine should strictly report the entries according to the CONSORT HARMs statement, and take the characteristics of traditional Chinese medicine into account to report the details of the Chinese medicine like compositions, dose, taking time, combined medication and the dialectical typology of research objects.
Drugs, Chinese Herbal
;
toxicity
;
Humans
;
Kidney
;
drug effects
;
Randomized Controlled Trials as Topic
;
Tripterygium
;
toxicity
10.Current research situation of nephrotoxicity of Chinese herbal medicine.
Xue FENG ; Sai-Nan FANG ; Yu-Xin GAO ; Jian-Ping LIU ; Wei CHEN
China Journal of Chinese Materia Medica 2018;43(3):417-424
To provide the basis for the future research on the nephrotoxicity of Chinese herbal medicine through systematic and comprehensive summary of all the Chinese herbal medicines which may lead to nephrotoxicity. Foreign resources included PubMed and Cochrane library, and domestic research resources was China Food and Drug Administration(CDFA) Adverse Drug Reaction Monitoring Center database. The databases were searched from establishment to January 1, 2017. There was no limitation on research type. 28 English studies were found, including 97 Chinese herbs or prescriptions with the risk of nephrotoxicity. The following six Chinese herbal medicines with the risk of nephrotoxicity had a large number of studies: aristolochic acid(5 studies), Tripterygium wilfordii(4 studies), Erycibe obtusifolia(2 studies), Rheum palmatum(2 studies), Ephedra sinica(2 studies), and Atractylodes lances(2 studies). The remaining 91 Chinese medicines were reported with risk of nephrotoxicity in only 1 study respectively. CDFA reported 16 Chinese herbal medicines with the risk of nephrotoxicity, including Ganmaoqing Pian(capsule), Zhenju Jiangya Pian, T. wilfordii preparation, Vc-Yinqiao Pian, Chuanhuning injection, Shuanghuanglian injection, Qingkailing injection, Lianbizhi injection, herbal decoction containing Aristolochiae Radix, Guanxin Suhe Wan, Shugan Liqi Wan, Ershiwuwei Songshi Wan, herbal decoction containing Aristolochia Fangchi, herbal granules containing root of Kaempfer Dutchmanspipe, Ganmaotong(tablets), and Longdan Xiegan Wan. Currently, in addition to aristolochic acids, the most reported Chinese herbal medicine with the risk of nephrotoxicity is T. wilfordii preparation.
Aristolochia
;
toxicity
;
China
;
Drugs, Chinese Herbal
;
toxicity
;
Ephedra sinica
;
toxicity
;
Humans
;
Kidney
;
drug effects
;
Tripterygium
;
toxicity